Clinical Trial Update: DECIFER: Depression and Citalopram In First Episode Recovery [Phase 4]

View source ↗

Summary

Phase 4 trial update for DECIFER evaluating depression and citalopram in first-episode recovery; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: NYU Langone Health | Conditions: Schizophrenia, Schizophreniform Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-11-16